Comparison of Performance of Various Tumor Response Criteria in Assessment of Regorafenib Activity in Advanced Gastrointestinal Stromal Tumors after Failure of Imatinib and Sunitinib

PURPOSE: To compare performance of various tumor response criteria (TRC) in assessment of regorafenib activity in patients with advanced GIST with prior failure of imatinib and sunitinib. METHODS: Twenty participants in a phase II trial received oral regorafenib (median duration 47 weeks; IQR 24-88)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Cancer
Autores principales: Shinagare, Atul B., Jagannathan, Jyothi P., Kurra, Vikram, Urban, Trinity, Manola, Judith, Choy, Edwin, Demetri, George D., George, Suzanne, Ramaiya, Nikhil H.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4242716/
https://ncbi.nlm.nih.gov/pubmed/24388774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2013.11.037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares